![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » U.S. BANK PARTNERS WITH ACCENTIA BIOPHARMACEUTICALS
U.S. BANK PARTNERS WITH ACCENTIA BIOPHARMACEUTICALS
May 1, 2006
U.S. Bank has provided the financing to help develop
apotentially life-saving therapeutic for non-Hodgkin's lymphoma,marking the first
time the New Market Tax Credit (NMTC) program hasbeen used to support a biopharmaceutical
company. As part of afinancing arranged with Accentia Biopharmaceuticals, Inc.,
U.S. Bank purchased $4.6 million of NMTCs as part of aninvestment in a subsidiary
of Biovest International, Inc.
Finanzen.net
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct